83 related articles for article (PubMed ID: 21140396)
1. Symmetry complementarity-guided design of anthrax toxin inhibitors based on β-cyclodextrin: Synthesis and relative activities of face-selective functionalized polycationic clusters.
Díaz-Moscoso A; Méndez-Ardoy A; Ortega-Caballero F; Benito JM; Ortiz Mellet C; Defaye J; Robinson TM; Yohannes A; Karginov VA; García Fernández JM
ChemMedChem; 2011 Jan; 6(1):181-92. PubMed ID: 21140396
[TBL] [Abstract][Full Text] [Related]
2. Beta-cyclodextrin derivatives that inhibit anthrax lethal toxin.
Karginov VA; Yohannes A; Robinson TM; Fahmi NE; Alibek K; Hecht SM
Bioorg Med Chem; 2006 Jan; 14(1):33-40. PubMed ID: 16169738
[TBL] [Abstract][Full Text] [Related]
3. Search for cyclodextrin-based inhibitors of anthrax toxins: synthesis, structural features, and relative activities.
Karginov VA; Nestorovich EM; Yohannes A; Robinson TM; Fahmi NE; Schmidtmann F; Hecht SM; Bezrukov SM
Antimicrob Agents Chemother; 2006 Nov; 50(11):3740-53. PubMed ID: 16982795
[TBL] [Abstract][Full Text] [Related]
4. Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.
Karginov VA; Nestorovich EM; Moayeri M; Leppla SH; Bezrukov SM
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15075-80. PubMed ID: 16214885
[TBL] [Abstract][Full Text] [Related]
5. Activity of the Bacillus anthracis 20 kDa protective antigen component.
Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
[TBL] [Abstract][Full Text] [Related]
6. In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin.
Moayeri M; Robinson TM; Leppla SH; Karginov VA
Antimicrob Agents Chemother; 2008 Jun; 52(6):2239-41. PubMed ID: 18378717
[TBL] [Abstract][Full Text] [Related]
7. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
Gupta M; Alam S; Bhatnagar R
Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of S. aureus alpha-hemolysin and B. anthracis lethal toxin by beta-cyclodextrin derivatives.
Karginov VA; Nestorovich EM; Schmidtmann F; Robinson TM; Yohannes A; Fahmi NE; Bezrukov SM; Hecht SM
Bioorg Med Chem; 2007 Aug; 15(16):5424-31. PubMed ID: 17572091
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of peptide-based anthrax toxin inhibitors.
Gujraty K; Sadacharan S; Frost M; Poon V; Kane RS; Mogridge J
Mol Pharm; 2005; 2(5):367-72. PubMed ID: 16196489
[TBL] [Abstract][Full Text] [Related]
10. Anthrax toxin: the long and winding road that leads to the kill.
Abrami L; Reig N; van der Goot FG
Trends Microbiol; 2005 Feb; 13(2):72-8. PubMed ID: 15680766
[TBL] [Abstract][Full Text] [Related]
11. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.
Zhang Y; Qiu J; Zhou Y; Farhangfar F; Hester J; Lin AY; Decker WK
Vaccine; 2008 Jan; 26(5):614-22. PubMed ID: 18166249
[TBL] [Abstract][Full Text] [Related]
12. Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.
Li H; Soroka SD; Taylor TH; Stamey KL; Stinson KW; Freeman AE; Abramson DR; Desai R; Cronin LX; Oxford JW; Caba J; Pleatman C; Pathak S; Schmidt DS; Semenova VA; Martin SK; Wilkins PP; Quinn CP
J Immunol Methods; 2008 Apr; 333(1-2):89-106. PubMed ID: 18304568
[TBL] [Abstract][Full Text] [Related]
13. Screening inhibitors of anthrax lethal factor.
Tonello F; Seveso M; Marin O; Mock M; Montecucco C
Nature; 2002 Jul; 418(6896):386. PubMed ID: 12140548
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analyses of murine macrophages treated with Bacillus anthracis lethal toxin.
Sapra R; Gaucher SP; Lachmann JS; Buffleben GM; Chirica GS; Comer JE; Peterson JW; Chopra AK; Singh AK
Microb Pathog; 2006; 41(4-5):157-67. PubMed ID: 16950595
[TBL] [Abstract][Full Text] [Related]
15. Soluble expression and purification of the anthrax protective antigen in E. coli and identification of a novel dominant-negative mutant N435C.
Wu G; Feng C; Hong Y; Guo A; Cao S; Dong J; Lin L; Liu Z
Appl Microbiol Biotechnol; 2010 Jun; 87(2):609-16. PubMed ID: 20213183
[TBL] [Abstract][Full Text] [Related]
16. Bacillus anthracis: a multi-faceted role for anthrax lethal toxin in thwarting host immune defenses.
Xu L; Frucht DM
Int J Biochem Cell Biol; 2007; 39(1):20-4. PubMed ID: 17008119
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice.
Sloat BR; Cui Z
J Pharm Pharmacol; 2006 Apr; 58(4):439-47. PubMed ID: 16597361
[TBL] [Abstract][Full Text] [Related]
18. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.
Sloat BR; Shaker DS; Le UM; Cui Z
FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342
[TBL] [Abstract][Full Text] [Related]
19. New insights into the functions of anthrax toxin.
Banks DJ; Ward SC; Bradley KA
Expert Rev Mol Med; 2006 Apr; 8(7):1-18. PubMed ID: 16608555
[TBL] [Abstract][Full Text] [Related]
20. [Toxin-neutralizing monoclonal antibodies to the different domains of anthrax protective antigen].
Xu JJ; Zhang J; Liu SL; Lv TJ; Chen W; Li GL; Ge M; Guo Q
Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):947-51. PubMed ID: 16496709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
